Pliant Therapeutics Banner Image

Pliant Therapeutics

  • Ticker PLRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Pliant Therapeutics Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to bothMore increase understanding of natural disease progression, and fuel biomarker discovery. Pliant’s co-founders include world-renowned researchers from the University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
Pliant Therapeutics

Most Recent Annual Report

Pliant Therapeutics
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Pliant Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!